@article {1623346,
	title = {Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors},
	journal = {Am J Ophthalmol},
	year = {2021},
	month = {2021 Nov 12},
	abstract = {PURPOSE: To estimate the incidence of corneal endothelial transplantation and identify risk factors among patients with non-infectious ocular inflammation. DESIGN: Retrospective cohort study. METHODS: Adult patients attending United States tertiary uveitis care facilities diagnosed with non-infectious ocular inflammation were identified from the Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Time-to-event analysis was used to estimate the incidence of corneal endothelial transplantation (CET), including penetrating keratoplasty, Descemet stripping endothelial keratoplasty, or Descemet Membrane Endothelial Keratoplasty procedures. The incidence of CET was calculated; potential risk factors for CET were also evaluated using Cox regression, accounting for correlation between eyes of the same patient. RESULTS: Overall, 14,264 eyes met eligibility criteria for this analysis with a median follow-up 1.8 eye-years. The Kaplan-Meier estimated incidence of CET within 10 years was 1.10\% (95\% CI, 0.68\%-1.53\%). Risk factors for CET included age \&gt;60 years vs. \&lt;40 years (aHR 16.5; 95\% CI,4.70-57.9), anterior uveitis and scleritis vs. other types (aHR 2.97; 95\% CI, 1.46-6.05 and aHR 4.14; 95\% CI,1.28-13.4, respectively), topical corticosteroid treatment (aHR 2.84; 95\% CI, 1.32-6.13), cataract surgery (aHR 4.44; 95\% CI, 1.73-11.4), tube shunt surgery (aHR 11.9; 95\% CI, 5.30-26.8), band keratopathy (aHR 5.12; 95\% CI, 2.34-11.2), and hypotony (aHR 7.38; 95\% CI, 3.14-17.4). Duration of uveitis, trabeculectomy, PAS, and ocular hypertension had no significant association after multivariate adjustment. CONCLUSIONS: In patients with ocular inflammation, CET occurred infrequently. Tube shunt surgery, hypotony, band keratopathy, cataract surgery, and anterior segment inflammation were associated with increased risk of undergoing corneal endothelial transplantation; these factors likely are associated with endothelial cell damage.},
	issn = {1879-1891},
	doi = {10.1016/j.ajo.2021.10.031},
	author = {Roldan, Ana M and Zebardast, Nazlee and Pistilli, Maxwell and Khachatryan, Naira and Payal, Abhishek and Begum, Hosne and Artornsombudh, Pichaporn and Pujari, Siddharth S and Rosenbaum, James T and Sen, H Nida and Suhler, Eric B and Thorne, Jennifer E and Bhatt, Nirali P and Foster, C Stephen and Jabs, Douglas A and Levy-Clarke, Grace A and Nussenblatt, Robert B and Buchanich, Jeanine M and Kempen, John H and Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group}
}
